Bionor Pharma ApS — Credit Rating and Financial Key Figures
CVR number: 36445564
Strandvejen 100, 2900 Hellerup
Income statement (kDKK)
2016 | |
---|---|
Fiscal period length | 12 |
Net sales | |
Gross profit | 7 876.38 |
Employee benefit expenses | -5 844.56 |
Total depreciation | -1 091.97 |
EBIT | 939.85 |
Other financial income | 31.66 |
Other financial expenses | -35.94 |
Pre-tax profit | 935.56 |
Income taxes | - 210.97 |
Net earnings | 724.59 |
Assets (kDKK)
2016 | |
---|---|
Intangible assets total | |
Tangible assets total | |
Investments total | |
Long term receivables total | |
Inventories total | |
Current amounts owed by group member comp. | 4 574.32 |
Short term receivables total | 4 574.32 |
Cash and bank deposits | 215.64 |
Cash and cash equivalents | 215.64 |
Balance sheet total (assets) | 4 789.96 |
Equity and liabilities (kDKK)
2016 | |
---|---|
Share capital | 1 000.00 |
Share premium account | 1 989.33 |
Retained earnings | 687.92 |
Profit of the financial year | 724.59 |
Shareholders equity total | 4 401.85 |
Non-current liabilities total | |
Current trade creditors | 16.48 |
Short-term deferred tax liabilities | 256.76 |
Other non-interest bearing current liabilities | 114.88 |
Current liabilities total | 388.12 |
Balance sheet total (liabilities) | 4 789.96 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.